SCHEMBL1886871

SCHEMBL1886871

C=CC(=O)N(O)S(=O)(=O)c1ccc[nH]1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1608668 0.69 NAPRT (0.32)
SCHEMBL28431729 0.67 ALDH1A1 (0.44) POLB
SCHEMBL736923 0.64
SCHEMBL2850012 0.64 DAO (0.37) POLB
SCHEMBL1059399 0.63 ALDH1A1 (0.41)
Hydrochloric Acid SCHEMBL27659745 0.63 DAO (0.38) POLB
SCHEMBL27534263 0.63 DAO (0.38) POLB
Benzene SCHEMBL28468895 0.63 TSHR (0.42) POLB
SCHEMBL22494215 0.62
SCHEMBL329181 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8785659-B2 Method for the production of sulphonylpyrroles as HDAC inhibitors 4SC AG (DE) 2014-07-22 US disclosed
EP-2265580-B1 NOVEL METHOD FOR THE PRODUCTION OF SULPHONYLPYRROLES AS HDAC INHIBITORS 4SC AG (DE) 2011-08-10 EP disclosed
US-20110105568-A1 NOVEL METHOD FOR THE PRODUCTION OF SULPHONYLPYRROLES AS HDAC INHIBITORS 4SC AG (DE) 2011-05-05 US disclosed
EP-2265580-A1 NOVEL METHOD FOR THE PRODUCTION OF SULPHONYLPYRROLES AS HDAC INHIBITORS 4SC AG (DE) 2010-12-29 EP disclosed
WO-2009112529-A1 NOVEL METHOD FOR THE PRODUCTION OF SULPHONYLPYRROLES AS HDAC INHIBITORS 4SC AG (DE) 2009-09-17 WO disclosed
EP-2100878-A1 Novel method for the production of sulphonylpyrroles as HDAC inhibitors 4SC AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110105568-A1 NOVEL METHOD FOR THE PRODUCTION OF SULPHONYLPYRROLES AS HDAC INHIBITORS HDAC1, HDAC2, HDAC3 POLB 2543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.